TAp73-mediated the activation of C-jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Zhang, Pingde ^a   Liu, Stephanie Si ^a   Ngan, Hextan Yuen Sheung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN P73; PROTEIN TAP73; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; OVARY CANCER; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CISPLATIN; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84864964240     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042985     Document Type: Article

References (30)

1. Murray-Zmijewski F, Lane DP, Bourdon JC, ((2006)) p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 13:: 962--972.
2. Boominathan L, ((2010)) The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 5:: e10615.
3. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, et al. ((2002)) DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 196:: 765--780.
4. Muller M, Schleithoff ES, Stremmel W, Melino G, Krammer PH, et al. ((2006)) One, two, three - p53, p63, p73 and chemosensitivity. Drug Resist Updat 9:: 288--306.
5. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, et al. ((2003)) Chemosensitivity linked to p73 function. Cancer Cell 3:: 403--410.
6. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG Jr, et al. ((1999)) The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:: 806--809.
7. Shimodaira H, Yoshioka-Yamashita A, Kolodner RD, Wang JY, ((2003)) Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci U S A 100:: 2420--2425.
8. Ramadan S, Terrinoni A, Catani MV, Sayan AE, Knight RA, et al. ((2005)) p73 induces apoptosis by different mechanisms. Biochem Bioph Res Co 331:: 713--717.
9. Ip YT, Davis RJ, ((1998)) Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol 10:: 205--219.
10. Davis RJ, ((2000)) Signal transduction by the JNK group of MAP kinases. Cell 103:: 239--252.
11. Dhanasekaran DN, Reddy EP, ((2008)) JNK signaling in apoptosis. Oncogene 27:: 6245--6251.
12. Brozovic A, Fritz G, Christmann M, Zisowsky J, Jaehde U, et al. ((2004)) Long-term activation of SAPK/JNK, p38 kinase and Fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Int J Cancer 112:: 974--985.
13. Jones EV, Dickman MJ, Whitmarsh AJ, ((2007)) Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase. Biochem J 405:: 617--623.
14. Sanchez-Perez I, Murguia JR, Perona R, ((1998)) Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16:: 533--540.
15. Mansouri A, Ridgway LD, Korapati AL, Zhang QX, Tian L, et al. ((2003)) Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 278:: 19245--19256.
16. Wei N, Liu SS, Leung THY, Tam KF, Liao XY, et al. ((2009)) Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol Cancer 8:: 1408--13.
17. Takekawa M, Saito H, ((1998)) A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95:: 521--530.
18. Zerbini LF, Wang YH, Czibere A, Correa RG, Cho JY, et al. ((2004)) NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45 alpha and-gamma is essential for cancer cell survival (vol 101, pg 13618, 2004). Proc Natl Acad Sci U S A 101:: 15271--15271.
19. Lee CW, La Thangue NB, ((1999)) Promoter specificity and stability control of the p53-related protein p73. Oncogene 18:: 4171--4181.
20. Zhu JH, Jiang JY, Zhou WJ, Chen XB, ((1998)) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 58:: 5061--5065.
21. Leong CO, Vidnovic N, DeYoung MP, Sgroi D, Ellisen LW, ((2007)) The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. J Clin Invest 117:: 1370--1380.
22. Ibrahim N, He L, Leong CO, Xing DY, Karlan BY, et al. ((2010)) BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma. Cancer Res 70:: 7155--7165.
23. Zhu JH, Nozell S, Wang J, Jiang JY, Zhou WJ, et al. ((2001)) p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene 20:: 4050--4057.
24. Das S, Nama S, Antony S, Somasundaram K, ((2005)) p73 beta-expressing recombinant adenovirus: a potential anticancer agent. Cancer gene ther 12:: 417--426.
25. Tournier C, Hess P, Yang DD, Xu J, Turner TK, et al. ((2000)) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:: 870--874.
26. Zhan QM, ((2005)) Gadd45a, a p53-and BRCA1-regulated stress protein, in cellular response to DNA damage. Mutat Res-Fund Mol M 569:: 133--143.
27. Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, et al. ((2002)) Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res 62:: 7305--7315.
28. Tront JS, Hoffman B, Liebermann DA, ((2006)) Gadd45a suppresses ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res 66:: 8448--8454.
29. Zhang X, Ling M-T, Feng H, Wong YC, Tsao SW, et al. ((2004)) ID-I stimulates cell proliferation through activation of EGFR in ovarian cancer cells. Br J Cancer 91:: 2042--2047.
30. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, et al. ((1981)) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68:: 1331--1337.